OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 99 filers reported holding OPHTHOTECH CORP in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,746,000 | +17.6% | 4,074,944 | +0.1% | 3.30% | -23.0% |
Q4 2018 | $4,887,000 | -10.9% | 4,072,301 | +75.2% | 4.29% | +33.8% |
Q3 2018 | $5,486,000 | +5.1% | 2,324,782 | +21.6% | 3.21% | +1.1% |
Q2 2018 | $5,220,000 | +19.6% | 1,912,018 | +20.0% | 3.17% | +35.6% |
Q1 2018 | $4,365,000 | -40.5% | 1,593,119 | -32.2% | 2.34% | -46.8% |
Q4 2017 | $7,332,000 | -25.4% | 2,350,000 | -32.6% | 4.39% | -24.2% |
Q3 2017 | $9,834,000 | +7.4% | 3,487,209 | -2.5% | 5.80% | +17.3% |
Q2 2017 | $9,155,000 | -28.9% | 3,576,189 | +1.7% | 4.94% | -31.8% |
Q1 2017 | $12,870,000 | +16.2% | 3,516,489 | +53.4% | 7.25% | +9.9% |
Q4 2016 | $11,075,000 | – | 2,292,900 | – | 6.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
IMA Advisory Services, Inc. | 67,930 | $3,161,000 | 1.54% |
Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |